With a new presidential administration come new (and dimmer) prospects for the rescheduling of cannabis. The rescheduling process, which began under President Biden, has met with legal hurdles and will now be overseen by a group of Trump appointees that view the drug less favorably. On a new episode of Policy Outsider, Rockefeller Institute director of operations, fellow, and resident cannabis policy expert, Heather Trela, provides an update on where we are in the process, the new players, and what to expect in the coming months.
